Area of research
Immunology · Oncology
Research interest
Research interests include Cytotoxic T cell, Cancer research, T cell, Priming (agriculture), CD8, and Tumor microenvironment.
Lung Cancer–Intrinsic SOX2 Expression Mediates Resistance to Checkpoint Blockade Therapy by Inducing Treg-Dependent CD8+ T-cell Exclusion
Tissue-specific abundance of interferon-gamma drives regulatory T cells to restrain DC1-mediated priming of cytotoxic T cells against lung cancer
Lung cancer-intrinsic SOX2 expression mediates resistance to checkpoint blockade therapy by inducing Treg-dependent CD8 <sup>+</sup> T cell exclusion
Lack of CD8 <sup>+</sup> T cell effector differentiation during priming mediates checkpoint blockade resistance in non–small cell lung cancer
320 Tumor cell-intrinsic signaling mediates T cell exclusion and promotes resistance to checkpoint blockade therapy in non-small cell lung cancer
664 Pulmonary priming of tumor-reactive CD8<sup>+</sup> T cells by DC1 is impaired by regulatory T cells